Dydrogesterone (Duphaston 10mg) is a synthetic progestogen generally used to provide supportive management for conditions and symptoms that arise from a functional progesterone deficiency or systemic imbalance. The overall purpose involves providing supportive relief for symptoms related to hormonal imbalance and reproductive areas; the medication is applied in situations where patients experience problems related to insufficient natural progesterone production.

The medication is commonly used across conditions presenting with episodic or fluctuating symptom patterns, including severe menstrual pain (dysmenorrhea), irregular menstrual periods, Premenstrual Syndrome (PMS), and the symptom burden of endometriosis. In reproductive health, it is applied when supportive symptom management is appropriate for the uterine lining, such as in cases of recurrent pregnancy loss or during Assisted Reproductive Technology (ART) regimens.

“This supportive role is considered relevant in contexts marked by increased discomfort or tension related to hormonal cycling.”

This progestogen generally supports the regulation of the menstrual rhythm, assists with functional stability for the uterine lining, and contributes to improved comfort during symptomatic periods by helping address symptoms that interfere with daily functioning.

---

Quick Fact: Relief for Cyclical Discomfort

Duphaston is commonly used to help manage symptoms related to the menstrual cycle, including cyclical pain and heavy bleeding, and is also applied when short-term symptomatic assistance is needed for early pregnancy support.

Regulatory References

1. Health Products Regulatory Authority of Ireland (HPRA) Summary of Product Characteristics

The population eligible to use Duphaston 10mg is strictly defined by official regulatory documentation. The medicine is established for use in adult women under specific conditions where progesterone support is required, provided no exclusionary factors are present.

Non-Eligibility and Restricted Use

Use is contraindicated and strictly prohibited for individuals with a known hypersensitivity to dydrogesterone or any excipients. It must also not be used by patients with a known or suspected progestogen-dependent malignancy, such as meningioma, or in the presence of undiagnosed vaginal bleeding.

Category	Official Regulatory Status
Age Limitations	Use is not recommended in children before menarche. Data for women over 65 years of age are limited.
Pregnancy/Lactation	Pregnancy: Use is restricted to specific labeled indications. Lactation: Use is not recommended as dydrogesterone is excreted in breast milk.
Organ Function	Caution is required in patients with impaired hepatic function. Use is contraindicated in Hormone Replacement Therapy (HRT) for women with active venous thromboembolism or active liver disease.

These rules define the official scope of use, reserving the medicine for the established adult population and formally excluding individuals with specific pre-existing conditions or physiological states.

The documented interaction profile for Dydrogesterone (Duphaston 10mg) is primarily defined by pharmacokinetic interactions that influence its metabolic clearance from the body. Co-administration with certain medicinal products and substances known to increase the activity of drug-metabolizing enzymes can significantly increase Dydrogesterone's rate of metabolisation. This regulatory outcome is formally described as a reduction in therapeutic effect which may also lead to changes in the bleeding pattern.

Pharmacokinetic Interactions (Metabolism)

Substances documented to increase the metabolism of Dydrogesterone include several categories of medicines. These include anticonvulsants such as phenytoin, carbamazepine, and phenobarbital, and specific anti-infective agents such as rifampicin and rifabutin. Certain HIV/HCV protease inhibitors including ritonavir and nelfinavir are also listed as having an enzyme-inducing action on steroid hormones.

Interactions with Herbal Products

The official prescribing information specifically names certain herbal preparations that are known to induce drug-metabolizing enzymes, leading to reduced Dydrogesterone exposure. These include St. John's Wort (Hypericum perforatum), valerian root, sage, and gingko biloba.

Combination Therapy and Restrictions

When Dydrogesterone is utilized in a combined hormone regimen with Estrogens, regulatory requirements mandate that all listed contraindications for the Estrogen component must be strictly adhered to. Furthermore, the overall risk profile of the combination must be considered. Caution is advised for patients with acute liver disease or severe hepatic impairment, as their reduced clearance capability impacts drug exposure.

Duphaston (dydrogesterone) is a synthetic progestogen that functions by selectively engaging key signaling pathways to modulate molecular sequences within target tissues.

---

Selective Progesterone Receptor Agonism

This mechanism involves the drug's direct interaction with the nuclear progesterone receptor (PR). Dydrogesterone acts as a selective agonist, initiating or suppressing specific gene transcription sequences. This cascade leads to the altered synthesis of regulatory proteins and modifies the expression profiles characteristic of the secretory phase, mimicking the physiological effects of endogenous progesterone.

---

Endometrial Signaling and Transformation

Within the uterine lining (endometrium), the drug modifies early molecular steps, thereby inducing morphological and functional changes consistent with the secretory endometrium. This action directly alters local pathway activity that governs tissue maturation.

---

Myometrial Contractility Modulation

This domain primarily involves rapid, non-genomic effects. Dydrogesterone engages mechanisms that diminish spontaneous and induced myometrial contractility by reducing the excitability threshold of smooth muscle cells in the uterine wall. This results in the physiological modulation of uterine muscle activity.

Administration and Dosage Patterns

Duphaston 10mg (Dydrogesterone) is administered via the oral route as a film-coated tablet. The tablet is typically swallowed whole with water; the score line present on the tablet serves only to facilitate swallowing and is not intended to divide the tablet into equal doses. The medicine may be taken with or without food.

Dosing Patterns and Frequency

The total daily dosage is variable, generally ranging from 10 mg to 30 mg per day. The regimen is typically cyclic, where administration is limited to specific days of the menstrual cycle (e.g., from day 11 to day 25), or duration-limited continuous use. For doses exceeding 10 mg per day, the tablets are taken in divided doses and distributed evenly over the day to maintain consistent drug exposure.

Typical Regimen Pattern	Dosing Range (Daily)	Use-Context Constraint
Cyclic Dosing	10 mg to 20 mg	Restricted to specific cycle days, typically 10 to 14 days per cycle.
Acute/Loading Dose	Up to 40 mg (initial dose)	Followed by a reduction once symptoms have ceased for one week.
Duration-Limited	10 mg daily	Continuous use, often prescribed up to the 20th week of pregnancy.

Missed Dose and Population Use

If a scheduled dose is missed, it is generally taken as soon as remembered, provided less than 12 hours have elapsed since the scheduled time. If more than 12 hours have passed, the missed dose is skipped, and the regular schedule resumed. The medication is not indicated for use before menarche, and efficacy has not been established in adolescents aged 12 to 18 years. This structured administration follows specific time windows required for hormonal support.

Research evidence / Overview of studies for Dydrogesterone (Duphaston 10mg)

Threatened Miscarriage

Research has explored the use of dydrogesterone in conditions characterized by periods of heightened symptoms in early pregnancy, focusing on outcomes related to systemic or functional imbalance. Studies examined patient-reported experiences and outcomes reflecting daily functioning during these short-term or episodic symptom patterns. The findings describe patterns observed in the studies related to pregnancy outcomes measured. Some studies reported how symptoms evolved in the observed populations, while others reported mixed findings.

However, the evidence quality varies across studies, and long-term effects are not fully established. While some research provides insight into short-term changes, data are still emerging, and certainty remains low. Comparative evidence is lacking to definitively assess how these findings relate to other studied approaches in conditions involving periods of heightened symptoms. The results apply only to the specific populations studied, and research is ongoing to clarify consistent patterns.

Recurrent Miscarriage

Dydrogesterone was studied for conditions characterized by fluctuating or episodic manifestations of pregnancy loss. The research examined outcomes related to systemic imbalance in women who experienced cycles of stability and flare-ups of this condition, monitoring whether the compound was associated with changes measured regarding pregnancy maintenance. Findings indicate patterns related to the study endpoints in some populations.

It is important to understand that research provides context but not individual predictions. Follow-up durations were limited in some of the studies, and evidence quality varies across studies. Subgroup findings are uncertain, meaning the specific groups who may be more or less likely to have this association are not clearly defined. Furthermore, data for certain groups remain insufficient, highlighting a need for more research exploring short-term symptom changes in diverse settings.

Key Studies & References

1. Public Assessment Report Scientific discussion Dydrogesteron Adalvo 10 mg film-coated tablets (dydrogesterone) NL/H/5824/001/DC
2. Diagnosis and treatment of luteal phase deficiency: a committee opinion (2021) - ASRM

Common questions about Duphaston 10mg (FAQ)

Q: How is Duphaston 10mg different from natural progesterone?

A: Dydrogesterone is a synthetic progestogen that has a unique chemical structure, known as a retrosteroid, which is similar to, but distinct from, progesterone naturally made by the body. Official documents indicate that this specific structure makes it highly selective for the progesterone receptor and gives it better oral availability than some alternatives. Regulatory data indicates Dydrogesterone is virtually devoid of central nervous system effects often associated with some other progestogens.

Q: What medical conditions is Duphaston 10mg approved to treat?

A: According to the official product information, Duphaston is approved for conditions linked to progesterone deficiency. These indications include the management of menstrual disorders such as painful or irregular cycles and endometriosis. It is also used to provide support for the luteal phase during infertility treatment or Assisted Reproductive Technology (ART) regimens.

Q: Can Duphaston 10mg be used for irregular periods?

A: Yes, the official regulatory documents list irregular menstrual cycles and dysfunctional uterine bleeding as indications for dydrogesterone. The medicine works to help promote a healthy change in the uterine lining, supporting the body's natural cycle regulation.

Q: Do doctors ever use Duphaston 10mg to help with fertility?

A: Yes, official indications confirm that Dydrogesterone is used in the context of fertility. It is prescribed for the treatment of infertility related to a luteal phase insufficiency and is used for luteal support as part of an Assisted Reproductive Technology (ART) treatment.

Q: What is the goal of taking Duphaston 10mg during a cycle?

A: In conditions requiring cyclical use, the primary therapeutic goal is to help promote the secretory transformation of the uterine lining, which mimics the effects of the natural hormone. This action helps maintain hormonal balance and, when prescribed with estrogen, is intended to reduce the risk of endometrial overgrowth.

Q: Are there any side effects from Duphaston 10mg that I should be concerned about?

A: The official product information notes that severe reactions require immediate medical attention. The document lists serious signs that may warrant evaluation, such as exceptionally severe headaches or symptoms that may indicate a venous thromboembolism (blood clot).

Q: Can Duphaston 10mg be taken if a person has liver problems?

A: Official documents advise caution for all patients with liver disease. The medicine is officially contraindicated, meaning its use is restricted, in the presence of serious liver disorders or a history of serious liver disorders until liver function returns to normal.

Q: Do men ever use Duphaston 10mg?

A: Regulatory documents clearly state that dydrogesterone is not indicated for use in males. The medicine is specifically established for use in adult women under progesterone-deficient conditions.

Q: Is it necessary to have certain health checks before starting Duphaston 10mg?

A: Regulatory guidance indicates that before treatment begins, an underlying organic cause for any abnormal uterine bleeding should be investigated. Furthermore, regular medical reassessment and monitoring for certain conditions, particularly when used in combination regimens, may be necessary during the course of treatment.

Q: How is the research evidence for Duphaston 10mg described by regulatory bodies?

A: Official reviews and studies have examined the effectiveness of dydrogesterone in its various indications. For instance, studies have concluded that dydrogesterone demonstrated non-inferiority for luteal phase support when compared to an established alternative treatment. In a prior regulatory review, a major body determined that the previous withdrawal of the drug from the market was not due to safety or effectiveness reasons.

Q: Can Duphaston 10mg make my existing conditions, like migraines, worse?

A: Official warnings indicate that if an existing exceptionally severe headache or migraine occurs for the first time or gets worse during treatment, medical evaluation may be necessary to determine if cessation of the medicine is required.

Q: Can Duphaston 10mg cause spotting or breakthrough bleeding?

A: Yes, according to the official product information, breakthrough bleeding and spotting are possible. These are considered changes in the bleeding pattern and are more likely to occur during the first few months after starting treatment.

Q: Is Duphaston 10mg the same as other progesterone tablets like Utrogestan?

A: Dydrogesterone (Duphaston) is a synthetic progestogen with a unique retrosteroid structure. While it performs a similar function to other progesterone compounds, research that has compared it with alternative forms of progesterone indicated that the oral dydrogesterone tablet was non-inferior in efficacy in those specific studies.

Q: What happens in the body when someone stops taking Duphaston 10mg?

A: When the progestogen component of a regimen is discontinued, the physiological process typically leads to a withdrawal bleed due to the drop in hormone levels. The official text notes that if bleeding or spotting continues after treatment is discontinued, further medical evaluation is generally needed to determine the cause.

Q: Can taking Duphaston 10mg cause mood swings or make me feel emotional?

A: Official documents list depression as an uncommon possible side effect. Regulatory information advises that patients with a history of depression require careful monitoring, and medical evaluation may be needed to determine if treatment cessation is required should severe depression recur during use.

Q: Can Duphaston 10mg be taken by women who are also taking oral contraceptives?

A: While official regulatory documents do not provide comprehensive guidance on every drug-drug combination, a clinical trial noted the exclusion of patients who had recently used oral contraceptives. Based on this, simultaneous use with combined hormonal contraception is not within the established research context documented by the relevant study.

Q: What are the main contraindications for Duphaston 10mg listed in the official documents?

A: The medicine is officially contraindicated, meaning its use is restricted, in individuals with a known hypersensitivity to the drug. Other main restrictions include undiagnosed vaginal bleeding, known or suspected sex hormone-dependent malignancies, and serious active liver disorders.

Q: Does Duphaston 10mg have any effect on blood sugar levels?

A: Official sources indicate that clinical studies have included monitoring changes in certain safety parameters, such as insulin and glucose levels. This suggests that researchers examine the potential for metabolic effects when assessing the drug's overall safety profile.

Q: What do official sources say about the safety of Duphaston 10mg?

A: Official sources have reviewed the drug's profile and history. For instance, a major regulatory body determined that the previous withdrawal of the drug from the market was not due to safety or effectiveness concerns. Furthermore, research has suggested a favorable safety and tolerability profile when used in certain specific pregnancy-related situations.

Q: Is Duphaston 10mg approved in countries like the US, UK, and Australia?

A: The active substance dydrogesterone is licensed and used globally. However, official records note that the medicine is currently not marketed in the US; it was previously withdrawn from the US, UK, and Australian markets for commercial reasons, which a major regulatory body confirmed was not due to safety or effectiveness concerns.

Q: Why is Duphaston 10mg sometimes prescribed as part of IVF treatment?

A: Dydrogesterone is indicated for luteal support as part of an Assisted Reproductive Technology (ART), such as IVF. This use is designed to help address the progesterone deficiency that can occur following ovarian stimulation, supporting the necessary conditions in the uterine lining.

Q: What are the common reasons people discontinue Duphaston 10mg?

A: Official warnings describe serious conditions for which cessation of treatment should be considered. These conditions include if an exceptionally severe headache, migraine, a marked increase in blood pressure, or symptoms that may indicate venous thromboembolism occur or worsen during use.

Q: What are the potential signs of an allergic reaction to Duphaston 10mg?

A: The official adverse reaction profile notes rare reports of hypersensitivity and angioedema. Angioedema is a serious reaction that involves rapid swelling, particularly of the face, tongue, and throat.

Q: Can Duphaston 10mg be crushed or chewed?

A: Official directions for use advise that the tablet should be swallowed whole with water. The official prescribing information specifies that the tablets are not intended to be crushed, chewed, or broken before ingestion.

Q: Does Duphaston 10mg affect bone density?

A: Dydrogesterone is used in combination hormone replacement therapy (HRT) regimens for the prevention of osteoporosis in postmenopausal women who are at high risk of fractures. This indicates its role in managing bone health in a combination setting.

Q: What should be done if someone accidentally takes too many Duphaston 10mg tablets?

A: There is limited specific information on overdose effects available in the official prescribing information. In general, based on experience with similar types of hormonal medicines, an overdose may potentially cause non-life-threatening symptoms such as nausea, vomiting, or vaginal bleeding.

Q: Is fatigue a documented side effect of Duphaston 10mg?

A: While fatigue is not explicitly listed as a common adverse reaction, official documents list somnolence (drowsiness) as a rare side effect. Somnolence is a related symptom categorized under central nervous system effects.

Q: What does 'endogenous progesterone' mean in relation to Duphaston 10mg?

A: The term 'endogenous' refers to something produced naturally within the body. In the context of this medicine, which is a synthetic progestogen, 'endogenous progesterone' refers to the natural progesterone that the body itself produces.

Q: Is Duphaston 10mg commonly used in women who are near menopause?

A: Yes, according to the official product information, dydrogesterone is used in combination with oestrogen as part of hormone replacement therapy (HRT). This use is intended to manage oestrogen deficiency symptoms in postmenopausal women.

Storage and Disposal Requirements

Storage and disposal of Duphaston 10 mg film-coated tablets must strictly follow the official instructions provided in the product labeling to maintain stability and prevent misuse.

Storage Conditions

Requirement	Official Instruction
Temperature Limit	Store below 30°C and do not freeze.
Container Rule	Keep the tablets in the original packaging.
Shelf Life	The official shelf life is 5 years; do not use after the expiry date.
Child Safety	Store securely out of the sight and reach of children.

Disposal Instructions

Unused or expired Duphaston tablets must be disposed of responsibly. They should not be flushed down the toilet or placed in household trash but must be returned to a pharmacist or a recognized drug take-back program for proper pharmaceutical waste disposal.